 | | PRD_002279 | | Name: | N-acetyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl-N-[(1R,4S,7S,10S,19S,22S,25S,28R)-28-{[(2R)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl}-25-(3-amino-3-oxopropyl)-4-[(1H-imidazol-3-ium-4-yl)methyl]-10,19-dimethyl-7,22-bis(2-methylpropyl)-3,6,9,20,23,26,30,36-octaoxo-2,5,8,21,24,27,31,37-octaazabicyclo[17.16.2]heptatriacontan-31-ium-10-yl]-6-azaniumyl-L-norleucinamide | | Formula: | C64 H109 N19 O15 | | Definition date: | 2018-06-13 | | Last modified: | 2018-06-13 |
|
 | | PRD_002308 | | Name: | DAMGO | | Formula: | C26 H35 N5 O6 | | Definition date: | 2018-06-13 | | Last modified: | 2018-06-13 |
|
 | | PRD_002303 | | Name: | [(3-{(3S,6S,9S,15R,20aS)-15-[(N-acetyl-L-phenylalanyl)amino]-3-(cyclohexylmethyl)-6-[(1H-indol-3-yl)methyl]-1,4,7,10,16-pentaoxoicosahydropyrrolo[1,2-a][1,4,7,10,13]pentaazacyclooctadecin-9-yl}propyl)amino](amino)methaniminium | | Formula: | C47 H66 N11 O7 | | Definition date: | 2018-05-30 | | Last modified: | 2018-05-30 |
|
 | | PRD_001186 | | Name: | Myosin-A, stapled peptide | | Formula: | C97 H175 N31 O23 S | | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | | Definition date: | 2013-11-06 | | Last modified: | 2017-12-15 |
|
 | | PRD_002230 | | Name: | L-alpha-aspartyl-6-azaniumyl-L-norleucyl-O-phosphono-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-valyl-N-{(3R)-6-{[amino(iminio)methyl]amino}-1-[2-(methoxycarbonyl)-3,5-dimethylphenyl]-2-oxohexan-3-yl}glycinamide | | Formula: | C48 H81 N12 O18 P | | Definition date: | 2016-05-04 | | Last modified: | 2017-12-15 |
|
 | | PRD_002275 | | Formula: | C35 H59 N14 O13 | | Definition date: | 2017-06-14 | | Last modified: | 2017-12-15 |
|
 | | PRD_002277 | | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | | Formula: | C64 H93 N23 O25 S3 | | Definition date: | 2017-08-30 | | Last modified: | 2017-12-15 |
|
 | | PRD_002263 | | Name: | N-[(1S)-1-cyclohexyl-2-{[3-(morpholin-4-yl)propanoyl]amino}ethyl]-N~2~-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alaninamide | | Formula: | C31 H47 N5 O4 S | | Definition date: | 2017-11-01 | | Last modified: | 2017-11-01 |
|
 | | PRD_001141 | | Name: | (3S,8aR)-N-((R)-chroman-4-yl)-2-((S)-2-cyclohexyl-2-((S)-2-(methylamino)propanamido)acetyl)octahydropyrrolo[1,2-a]pyrazine-3-carboxamide | | Formula: | C29 H43 N5 O4 | | Definition date: | 2013-08-28 | | Last modified: | 2017-09-14 |
|
 | | PRD_002261 | | Formula: | C92 H138 N27 O24 S | | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | | Definition date: | 2017-05-24 | | Last modified: | 2017-05-24 |
|
 | | PRD_001131 | | Name: | GRAMICIDIN A | | Formula: | C90 H133 N19 O17 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2013-07-02 | | Last modified: | 2017-05-04 |
|
 | | PRD_001132 | | Name: | CYCLOSPORIN D | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | | Definition date: | 2013-07-02 | | Last modified: | 2017-05-04 |
|
 | | PRD_002251 | | Name: | 3-[(3-hydroxyphenyl)methyl]-10,12-dimethoxy-9,11-dimethyl-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | | Formula: | C34 H50 N4 O8 | | Definition date: | 2017-01-25 | | Last modified: | 2017-05-04 |
|
 | | PRD_002240 | | Name: | 18-methoxy-2,11,17-trimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C30 H44 N4 O6 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002241 | | Name: | 3-[(3-hydroxyphenyl)methyl]-6-(propan-2-yl)-19-oxa-1,4,7,25-tetraazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | | Formula: | C30 H42 N4 O6 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002245 | | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-17-methyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C35 H46 N4 O7 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002246 | | Name: | 11-[(3-hydroxyphenyl)methyl]-18-methoxy-2,17-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,28-tetraazatricyclo[21.3.1.1~5,9~]octacosa-1(27),21,23,25-tetraene-4,10,13,16-tetrone | | Formula: | C36 H48 N4 O7 | | Definition date: | 2017-01-25 | | Last modified: | 2017-01-25 |
|
 | | PRD_002186 | | Name: | 6-ammonio-N-[3-(9H-fluoren-9-yl)propanoyl]-L-norleucyl-6-ammonio-L-norleucyl-L-alpha-glutamyl-L-threonyl-L-alpha-glutamyl-L-valine | | Formula: | C47 H70 N8 O13 | | Definition date: | 2016-08-17 | | Last modified: | 2016-08-17 |
|
 | | PRD_001260 | | Name: | PAMK PEPTIDE Inhibitor | | Formula: | C48 H80 N12 O15 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002162 | | Name: | N-[(4-carbamimidamidobutyl)carbamoyl]-L-seryl-N-[(2S)-5-{[amino(iminio)methyl]amino}-1-oxopentan-2-yl]-L-valinamide | | Formula: | C20 H41 N10 O5 | | Definition date: | 2016-05-04 | | Last modified: | 2016-05-04 |
|
 | | PRD_002222 | | Name: | N-(3-bromo-4-methoxybenzene-1-carbonyl)-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C38 H53 Br N7 O11 P | | Definition date: | 2016-02-24 | | Last modified: | 2016-02-24 |
|
 | | PRD_002208 | | Formula: | C43 H66 N6 O8 | | Definition date: | 2015-12-16 | | Last modified: | 2015-12-16 |
|
 | | PRD_002211 | | Name: | (2~{S})-~{N}-[(1~{R},2~{S})-1-cyano-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepiperidin-3-yl]propan-2-yl]-3-phenyl-2-[[(~{E})-3-phenylprop-2-enoyl]amino]propanamide | | Formula: | C27 H30 N4 O4 | | Definition date: | 2015-12-09 | | Last modified: | 2015-12-09 |
|
 | | PRD_000929 | | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-hydroxypropan-2-yl]-L-isoleucinamide | | Formula: | C22 H38 N4 O9 | | Definition date: | 2015-12-02 | | Last modified: | 2015-12-02 |
|
 | | PRD_000841 | | Name: | CARBOXYPROPYL-BETA-THIOGALACTOSIDE-LYS-PRO-LEUNH2 | | Formula: | C26 H48 N5 O9 S | | Definition date: | 2015-09-16 | | Last modified: | 2015-09-16 |
|
